MedTrace Logo

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

NCT02592174 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2018-01-08

No results posted yet for this study

Summary

The primary objective is to measure the prevalence of according to the Frascati classification in a HIV-infected population aged between 55 and 70 years (exposed group) and to compare it with the prevalence of HIV-Associated Neurocognitive Disorders (HAND) in unexposed subjects from the general population-based cohort CONSTANCES, matching subjects on age, gender, geographical origin and socioprofessional category.

Conditions

  • HIV-1 Infection

Interventions

OTHER

Health related quality of life and social and demographic informations

At the inclusion visit with a self-assessment questionnaire

OTHER

Neurocognitive assessment

At the neurocognitive visit, with standard test as CONSTANCES cohort

RADIATION

cerebral images sub-study

Standard magnetic resonance imaging

Sponsors & Collaborators

Principal Investigators

  • Claudine Berr · Inserm U1061

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-26
Primary Completion
2017-10-27
Completion
2017-10-27

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592174 on ClinicalTrials.gov